A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents.

ABSTRACT: Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.

SUBMITTER: Giuffrida G 

PROVIDER: S-EPMC7869404 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature